Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells
2009

Identifying Genes Linked to Breast Cancer Progression

publication Evidence: moderate

Author Information

Author(s): Kurisetty Vittal V, Johnston Patrick G, Rudland Philip S, El-Tanani Mohamed K

Primary Institution: Centre for Cancer Research and Cell Biology (CCRCB), Queen's University Belfast

Hypothesis

How does osteopontin influence gene expression related to breast cancer malignancy?

Conclusion

The study suggests that osteopontin may enhance malignant properties in breast cancer cells through the overexpression of certain genes.

Supporting Evidence

  • Osteopontin is linked to increased malignancy in breast cancer.
  • The study identified 982 expressed sequence tags (ESTs) and 659 known genes.
  • RAN GTPase was found to be one of the most differentially expressed genes.

Takeaway

This study looked at how a protein called osteopontin affects genes in breast cancer cells, helping us understand why some cells become more aggressive.

Methodology

The study used suppressive subtractive hybridization to evaluate gene expression differences between benign and malignant rat mammary cell lines.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1756-0500-2-15

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication